Glutamate uptake

NC Danbolt - Progress in neurobiology, 2001 - Elsevier
Brain tissue has a remarkable ability to accumulate glutamate. This ability is due to
glutamate transporter proteins present in the plasma membranes of both glial cells and …

The pharmacology and mechanism of action of riluzole

A Doble - Neurology, 1996 - AAN Enterprises
The excitotoxic hypothesis of neurodegeneration has stimulated much interest in the
possibility of using compounds that will block excitotoxic processes to treat neurologic …

C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca2+-permeable AMPA receptor-mediated excitotoxicity

BT Selvaraj, MR Livesey, C Zhao, JM Gregory… - Nature …, 2018 - nature.com
Mutations in C9ORF72 are the most common cause of familial amyotrophic lateral sclerosis
(ALS). Here, through a combination of RNA-Seq and electrophysiological studies on …

Role of excitatory amino acid transporter‐2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics

K Kim, SG Lee, TP Kegelman, ZZ Su… - Journal of cellular …, 2011 - Wiley Online Library
Glutamate is an essential excitatory neurotransmitter regulating brain functions. Excitatory
amino acid transporter (EAAT)‐2 is one of the major glutamate transporters expressed …

The role of excitotoxicity in neurodegenerative disease: implications for therapy

A Doble - Pharmacology & therapeutics, 1999 - Elsevier
Glutamic acid is the principal excitatory neurotransmitter in the mammalian central nervous
system. Glutamic acid binds to a variety of excitatory amino acid receptors, which are ligand …

Impairment of mitochondrial calcium buffering links mutations in C9ORF72 and TARDBP in iPS-derived motor neurons from patients with ALS/FTD

R Dafinca, P Barbagallo, L Farrimond, A Candalija… - Stem Cell Reports, 2020 - cell.com
TDP-43 dysfunction is common to 97% of amyotrophic lateral sclerosis (ALS) cases,
including those with mutations in C9orf72. To investigate how C9ORF72 mutations drive …

[HTML][HTML] The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis

L Van Den Bosch, P Van Damme, E Bogaert… - … et Biophysica Acta (BBA …, 2006 - Elsevier
Unfortunately and despite all efforts, amyotrophic lateral sclerosis (ALS) remains an
incurable neurodegenerative disorder characterized by the progressive and selective death …

Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis

CLG Lin, LA Bristol, L Jin, M Dykes-Hoberg, T Crawford… - Neuron, 1998 - cell.com
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is characterized by
selective upper and lower motor neuron degeneration, the pathogenesis of which is …

Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes

SG Lee, ZZ Su, L Emdad, P Gupta, D Sarkar… - Journal of Biological …, 2008 - ASBMB
Glutamate is an essential neurotransmitter regulating brain functions. Excitatory amino acid
transporter (EAAT)-2 is one of the major glutamate transporters primarily expressed in …

Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis

PR Heath, PJ Shaw - Muscle & Nerve: Official Journal of the …, 2002 - Wiley Online Library
Excitotoxicity may play a role in certain disorders of the motor system thought to be caused
by environmentally acquired toxins, including lathyrism and domoic acid poisoning. Motor …